Skip to main content
Clinical Trials/CTRI/2020/12/029894
CTRI/2020/12/029894
Not yet recruiting
未知

Comparing the effectiveness of Dexamethasone versus Methylprednisolone in patients with moderate Covid 19 - A Randomised controlled trial - DMC

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
SRM Medical College Hospital and Research Centre
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Hospitalized patients with moderate SARS\-COV\-2 infection laboratory confirmed by RT\-PCR
  • (Moderate COVID 19\- SPO2 \<94% Under room air and requiring supplemental oxygen for hypoxemia
  • Respiratory rate 24\-30/min
  • CRP 50\-100 mg/l
  • Serum ferritin 600\-1500 ng/ml
  • Serum LDH 300\-500 IU/l
  • D Dimer 0\.5\-1\.0 mic/ml
  • IL\-6 20\-100 pg/ml
  • CT chest showing 25\-75% infiltrates)

Exclusion Criteria

  • 1\.Patients with mild and severe covid pneumonia
  • 2\.Patients who are already on steroid treatment for any underlying condition
  • 3\.Patients already started on antivirals
  • 4\.Pregnant or lactating women
  • 5\.Any known contraindication to short term corticosteroid like severe immunosuppression, HIV infection or any other immunosuppressant usage

Outcomes

Primary Outcomes

Not specified

Similar Trials